Patient Delay in Accessing Breast Cancer Care in a Sub Saharan African Country: Uganda
Moses Galukande, Florence Mirembe, Henry Wabinga
Journal of Advances in Medicine and Medical Research · pp. 2599–2610 · Published 19 Feb 2014
10.9734/BJMMR/2014/7293Abstract
Aims: To assess patient delay differences between early and late stage breast cancer among women in Uganda. Study Design: A retrospective analytical study. Place and Duration of the Study: A study conducted at a tertiary teaching hospital. Selected patients’ data available for the period between 2008 and 2011 were included in this study. Methodology: We included 201 women with histologically confirmed breast cancer. The variables analysed included age, residence, histological subtype, stage at presentation and time delays. Ethical approval was obtained. Results: The mean age for the early and late presenters was 49 and 46 years respectively (p=0.065). Rural women were more likely to present late. Triple negative breast cancer (TNBC) and HER2+ were the majority cancer subtypes for the late presenters. On average women waited for 29 months before they presented for specialized cancer treatment (median 12 months; range 1-120 months). The duration of symptoms didn’t differ between the two groups (p=0.295) and 75% of early stage presenters, reported at least 6 months after noticing symptoms. Only 9% of the TNBC patients presented under 3 months in comparison to 14 % for HER2+, 33% for Luminal B and 36% for luminal A. Overall 23% (39/168) presented with early stage disease. Conclusion: Delay in seeking appropriate breast cancer care in Uganda was excessive, a sign of a neglected disease. Tumor biology factors seem to play a role in late stage presentation. Research in factors that lead to prolonged delay in accessing care in a resource poor context are needed urgently.
Cited by 79
Aloysius G Mubuuke, Rita Nassanga, Moses Galukande · Journal of Global Health Reports · 2023
J. Odongo, T. Makumbi, S. Kalungi · BMC Research Notes · 2015
Rohini K. Bhatia, Sarah Rayne, William Rate · Journal of Global Oncology · 2018
John R. Scheel, Scott Parker, Daniel S. Hippe · The Oncologist · 2018
Olayide S. Agodirin, Isiaka Aremu, Ganiyu A. Rahman · JCO Global Oncology · 2020
Alaaddin M Salih, Musab M Alfaki, Dafallah M Alam-Elhuda · Asian Pacific Journal of Cancer Prevention · 2016
Jake W. Sharp, Daniel S. Hippe, Gertrude Nakigudde · PLOS ONE · 2019
Gloria Gbenonsi, Mouna Boucham, Zakaria Belrhiti · BMC Public Health · 2021
Elizabeth Namukwaya, Amos Deogratius Mwaka, Eve Namisango · Palliative Care for Chronic Cancer Patients in the Community · 2020
Jien Yen Soh, Maya Mazuwin Yahya, Norsa’adah Bachok · BMC Women's Health · 2022
Showing 20 of 79 known citations — external sources report more than can currently be individually listed.
Related research
- Reproductive Factors Associated with the Risk of Breast Cancer among Malaysian Women: A Multi-Centre Case-Control Study — shares topic coverage
- Factors Predicting the Utilization of Breast Cancer Screening Services among Women Working in a Private University in Ogun State, Nigeria — shares topic coverage
- Breast Cancer Screening Trend Year 2017 among South-Western Nigeria Female Residents — shares topic coverage
- Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
- Breast Cancer Knowledge and Mammography Uptake among Women Aged 40 Years and Above in Calabar Municipality, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
45
Page views
0
PDF downloads
4
Outbound clicks
79
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.